oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

NETSPOT

A quality defect of the NETSPOT product was identified – stability test results showed the content of the active substance DOTATATE close to the lower limit of the specification, meaning that established quality requirements are not met. Potential effects: lack of diagnostic efficacy, risk of delayed disease diagnosis.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

NETSPOT
Risk Level
Critical
Manufacturer
Advanced Accelerator Applications USA
Batch Number
PG1921019, PG1921020
Recall Date
12.04.2022
View official statement

Important Information

What You Should Know

Recommendations

Do not use batches PG1921019 and PG1921020. Check the batch number of the product in possession and, if it matches, return it to the dispensing entity and consult a physician regarding further managem...

Actions Taken

The Chief Pharmaceutical Inspector withdrew NETSPOT batches PG1921019 and PG1921020 from the market throughout the country and granted the decision immediate enforceability, obliging the marketing aut...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: A quality defect of the NETSPOT product was identified – stability test results showed the content of the active substance DOTATATE close to the lower limit of the specification, meaning that established quality requirements are not met. Potential effects: lack of diagnostic efficacy, risk of delayed disease diagnosis.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: PG1921019, PG1921020

Related

Other Recalled Products